Skip to content

SCHEDULE 13GAccepted Oct 13, 4:01 PM ET

ArriVent BioPharma, Inc. SCHEDULE 13G

AVBPArriVent BioPharma, Inc.

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

4:01 PM

Oct 13, 2026

Filed

Oct 13, 2026

Documents

2

Size

25.4 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.